Nevertheless, the fact that it was successful for most entities, including the first ETV6::NTRK3-driven model and orthotopic ASPSCR1::TFE3 model outside the cranial vault25, clearly suggests that this method is applicable to many other sarcoma subtypes. This evidence concerns the gene ETV6 and sarcoma.